Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 12128219 Intelligent medication delivery systems and methods
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
October 12, 2022
0
Date of Patent
October 29, 2024
0
Patent Application Number
17964149
0
Patent Citations
US Patent 9050413 Integrated delivery device for continuous glucose sensor
0
US Patent 9775543 Transcutaneous analyte sensor
0
US Patent D808986 Display panel with animated graphical user interface
0
US Patent D809544 Display screen with graphical user interface
0
US Patent D809545 Display screen with graphical user interface
0
US Patent D811425 Display screen or portion thereof with graphical user interface
0
US Patent D815127 Display screen or portion thereof with graphical user interface
0
US Patent D815667 Computing device display screen or portion thereof with an icon
0
US Patent 9937293 Integrated delivery device for continuous glucose sensor
0
US Patent D819043 Display panel or screen with an animated graphical user interface
0
•••
Patent Inventor Names
Sean Saint
0
Mike Mensinger
0
Arnold Holmquist
0
Jack Pryor
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
12128219
0
Patent Primary Examiner
Phillip A Gray
0
CPC Code
G01D 5/24461
0
G01D 5/24476
0
G01D 5/3473
0
G01D 5/2497
0
A61B 5/14532
0
A61B 5/0002
0
A61B 5/4836
0
A61B 5/4839
0
A61B 2034/2059
0
G16H 20/10
0
•••
Find more entities like US Patent 12128219 Intelligent medication delivery systems and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE